Log in

NASDAQ:PRAH - PRA Health Sciences Stock Price, Forecast & News

$111.22
+1.06 (+0.96 %)
(As of 02/17/2020 06:00 AM ET)
Add
Today's Range
$109.10
Now: $111.22
$111.36
50-Day Range
$101.21
MA: $106.56
$111.22
52-Week Range
$85.00
Now: $111.22
$115.50
Volume261,314 shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio30.89
Dividend YieldN/A
BetaN/A
PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:PRAH
CUSIPN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16,400
Next Earnings Date2/20/2020 (Confirmed)
OptionableOptionable

Receive PRAH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRAH and its competitors with MarketBeat's FREE daily newsletter.


PRA Health Sciences (NASDAQ:PRAH) Frequently Asked Questions

What is PRA Health Sciences' stock symbol?

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

How were PRA Health Sciences' earnings last quarter?

PRA Health Sciences Inc (NASDAQ:PRAH) announced its earnings results on Wednesday, October, 30th. The medical research company reported $1.32 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.29 by $0.03. The medical research company had revenue of $780.70 million for the quarter, compared to analyst estimates of $771.64 million. The business's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.13 EPS. View PRA Health Sciences' Earnings History.

When is PRA Health Sciences' next earnings date?

PRA Health Sciences is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for PRA Health Sciences.

How can I listen to PRA Health Sciences' earnings call?

PRA Health Sciences will be holding an earnings conference call on Thursday, February 20th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for PRAH?

10 analysts have issued 12 month price targets for PRA Health Sciences' shares. Their forecasts range from $100.00 to $123.00. On average, they anticipate PRA Health Sciences' stock price to reach $116.44 in the next twelve months. This suggests a possible upside of 4.7% from the stock's current price. View Analyst Price Targets for PRA Health Sciences.

What is the consensus analysts' recommendation for PRA Health Sciences?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PRA Health Sciences in the last year. There are currently 6 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for PRA Health Sciences.

Has PRA Health Sciences been receiving favorable news coverage?

Media headlines about PRAH stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. PRA Health Sciences earned a coverage optimism score of 1.8 on InfoTrie's scale. They also assigned headlines about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for PRA Health Sciences.

Are investors shorting PRA Health Sciences?

PRA Health Sciences saw a increase in short interest in January. As of January 31st, there was short interest totalling 2,460,000 shares, an increase of 17.7% from the January 15th total of 2,090,000 shares. Based on an average trading volume of 523,200 shares, the days-to-cover ratio is currently 4.7 days. Currently, 3.9% of the shares of the company are sold short. View PRA Health Sciences' Current Options Chain.

What other stocks do shareholders of PRA Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PRA Health Sciences investors own include NVIDIA (NVDA), Alibaba Group (BABA), Adobe (ADBE), Paypal (PYPL), Applied Materials (AMAT), Veeva Systems (VEEV), Lam Research (LRCX), Arista Networks (ANET), Walt Disney (DIS) and ABIOMED (ABMD).

Who are PRA Health Sciences' key executives?

PRA Health Sciences' management team includes the folowing people:
  • Mr. Colin Shannon, Chairman, CEO & Pres (Age 60)
  • Mr. Michael J. Bonello, Exec. VP, CFO & Corp. Sec. (Age 49)
  • Mr. Kent Thoelke, Exec. VP & Chief Scientific Officer
  • Mr. Thomas Byrne, VP of Legal Affairs
  • Christine Rogers, Director of PR & Corp. Communications

When did PRA Health Sciences IPO?

(PRAH) raised $306 million in an initial public offering (IPO) on Thursday, November 13th 2014. The company issued 17,000,000 shares at $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

Who are PRA Health Sciences' major shareholders?

PRA Health Sciences' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (2.70%), State Street Corp (2.27%), Pendal Group Ltd (1.52%), Eagle Asset Management Inc. (1.17%), AQR Capital Management LLC (1.15%) and Bank of New York Mellon Corp (1.08%). Company insiders that own PRA Health Sciences stock include Fund Holdings LP Kkr and Pra Investors LP Kkr. View Institutional Ownership Trends for PRA Health Sciences.

Which major investors are selling PRA Health Sciences stock?

PRAH stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, AQR Capital Management LLC, Pictet Asset Management Ltd., Artemis Investment Management LLP, Acadian Asset Management LLC, Strs Ohio, Magnetar Financial LLC and Jane Street Group LLC. View Insider Buying and Selling for PRA Health Sciences.

Which major investors are buying PRA Health Sciences stock?

PRAH stock was acquired by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Captrust Financial Advisors, FMR LLC, Goldman Sachs Group Inc., Mackay Shields LLC, Assenagon Asset Management S.A., Franklin Resources Inc. and Madison Asset Management LLC. View Insider Buying and Selling for PRA Health Sciences.

How do I buy shares of PRA Health Sciences?

Shares of PRAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is PRA Health Sciences' stock price today?

One share of PRAH stock can currently be purchased for approximately $111.22.


MarketBeat Community Rating for PRA Health Sciences (NASDAQ PRAH)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  344 (Vote Outperform)
Underperform Votes:  315 (Vote Underperform)
Total Votes:  659
MarketBeat's community ratings are surveys of what our community members think about PRA Health Sciences and other stocks. Vote "Outperform" if you believe PRAH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRAH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel